Fairtree Asset Management Pty Ltd Invests $1.33 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Fairtree Asset Management Pty Ltd bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 2,635 shares of the healthcare conglomerate's stock, valued at approximately $1,333,000. UnitedHealth Group accounts for about 1.3% of Fairtree Asset Management Pty Ltd's investment portfolio, making the stock its 19th biggest position.

Other institutional investors also recently added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. TD Securities restated a "hold" rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research report on Thursday, May 15th. Mizuho dropped their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Finally, TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $441.87.

UnitedHealth Group Trading Up 0.8%

Shares of NYSE UNH traded up $2.49 on Wednesday, reaching $297.49. 15,953,133 shares of the company traded hands, compared to its average volume of 6,708,326. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a 50 day moving average of $439.50 and a 200 day moving average of $498.65. The stock has a market capitalization of $269.87 billion, a PE ratio of 19.19, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the company earned $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the company's stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now owns 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 in the last ninety days. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.